Delivery Order SPE2DB22D1202-SPE2DB25FVGM9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,288.69 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical fulfillment under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $6,717.68. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for ultimate completion on August 15, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,634.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $14,076.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $48,933.00 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,489.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 13, 2025, with a completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply support to federal healthcare systems. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.47 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $5,457.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $35,131.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a direct supply of the diabetes medication to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGM9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,046.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's status as a prime vendor reflects its capability to meet federal procurement requirements and serve critical customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 8/5/25 |